Novel 7-{[2-(4-hydroxyphenyl)methylidene]amino}-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1azabicyclo [4.2.0]oct-2-ene-2-carboxylic acid was prepared by condensation of ceftriaxone disodium (1) with 4-hydroxybenzaldehyde (2) in ethanol under reflux conditions for 3-4 h. The structure of synthesized compound was elucidated using LCMS, 1 H-NMR, and CHN techniques.
Introduction
Since many years, ever-increasing resistance against human pathogens that cause serious infections is one of the main topics of attention for the medicinal chemist. Third generation cephalosporin antibiotic ceftriaxone has broad spectrum against human pathogens. Ceftriaxone has got high status among the class of cephalosporin but is no more effective than first and second generation cephalosporin. It has been used for the treatment of Lyme disease, typhoid fever, and gonorrhea.
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Ceftriaxone is effective in the treatment of various infections caused by pathogens including lower respiratory tract, abdomen, meninges, band and joint, pelvic area, urinary tract, skin and soft tissues. It is also commonly used in febrile infants of 4-8 weeks [1] [2] [3] [4] [5] .
Result and Discussion
Ceftriaxone is susceptible for the synthesis of Schiff bases. Off-white colored Schiff base was obtained in ethanol under the reflux conditions for 3-4 h (Scheme 1).
Scheme 1.
Reaction of ceftriaxone and 4-hydroxybenzaldehyde. 
Experimental
The melting point was taken in capillary using Gallenkamp MF-370. The purity of compounds was determined by using TLC. 
